Zekai Mao

1.3k total citations
18 papers, 382 citations indexed

About

Zekai Mao is a scholar working on Molecular Biology, Oncology and Rheumatology. According to data from OpenAlex, Zekai Mao has authored 18 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Rheumatology. Recurrent topics in Zekai Mao's work include CAR-T cell therapy research (7 papers), Osteoarthritis Treatment and Mechanisms (6 papers) and Virus-based gene therapy research (4 papers). Zekai Mao is often cited by papers focused on CAR-T cell therapy research (7 papers), Osteoarthritis Treatment and Mechanisms (6 papers) and Virus-based gene therapy research (4 papers). Zekai Mao collaborates with scholars based in China. Zekai Mao's co-authors include Hongbo You, Xiaojian Huang, Xi Yang, Xiangyu Chu, Bowei Ni, Pengcheng Wang, Rui Zhang, Rui Zhang, Rui Lu and Hao Cheng and has published in prestigious journals such as Blood, Frontiers in Immunology and European Journal of Pharmacology.

In The Last Decade

Zekai Mao

16 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zekai Mao China 12 186 127 79 70 47 18 382
Anna‐Lena Mueller Germany 10 234 1.3× 124 1.0× 61 0.8× 52 0.7× 63 1.3× 15 579
Myung-Soon Sung South Korea 7 212 1.1× 109 0.9× 56 0.7× 71 1.0× 49 1.0× 7 432
Sung Chul Kwak South Korea 12 257 1.4× 49 0.4× 103 1.3× 67 1.0× 41 0.9× 17 412
Niloufar Mohammadkhani Iran 9 190 1.0× 85 0.7× 100 1.3× 26 0.4× 66 1.4× 11 467
Mozhen Liu China 12 217 1.2× 59 0.5× 45 0.6× 94 1.3× 43 0.9× 30 469
Supriya Jagga South Korea 8 177 1.0× 193 1.5× 57 0.7× 78 1.1× 45 1.0× 19 483
Yonghui Dong China 12 335 1.8× 62 0.5× 134 1.7× 153 2.2× 60 1.3× 21 577
Bowei Ni China 12 192 1.0× 135 1.1× 27 0.3× 70 1.0× 52 1.1× 16 362
Nianhu Li China 10 248 1.3× 61 0.5× 49 0.6× 67 1.0× 59 1.3× 34 417
Yin Zhao China 7 217 1.2× 42 0.3× 60 0.8× 33 0.5× 63 1.3× 18 456

Countries citing papers authored by Zekai Mao

Since Specialization
Citations

This map shows the geographic impact of Zekai Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zekai Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zekai Mao more than expected).

Fields of papers citing papers by Zekai Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zekai Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zekai Mao. The network helps show where Zekai Mao may publish in the future.

Co-authorship network of co-authors of Zekai Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Zekai Mao. A scholar is included among the top collaborators of Zekai Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zekai Mao. Zekai Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Wang, Hanyu, Gaoxiang Wang, Peiling Zhang, et al.. (2025). Efficacy and safety of a novel CD19, CD22 dual-targeted fully human loop bi-CAR-T for the treatment of relapsed/refractory B cell non-Hodgkin lymphoma. Journal of Translational Medicine. 23(1). 630–630. 2 indexed citations
3.
Mao, Zekai, et al.. (2024). Epidemiological features and a survival nomogram for primary lymphoma of the male genital tract. Annals of Hematology. 103(5). 1687–1695.
4.
5.
Zhang, Peiling, Xiuxiu Yang, Yang Cao, et al.. (2022). Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphoma. Experimental Hematology and Oncology. 11(1). 72–72. 13 indexed citations
6.
Wei, Jia, Min Xiao, Zekai Mao, et al.. (2022). Outcome of aggressive B-cell lymphoma with TP53 alterations administered with CAR T-cell cocktail alone or in combination with ASCT. Signal Transduction and Targeted Therapy. 7(1). 101–101. 37 indexed citations
7.
You, Hongbo, et al.. (2021). Chondro-Protective Effects of Shikimic Acid on Osteoarthritis via Restoring Impaired Autophagy and Suppressing the MAPK/NF-κB Signaling Pathway. Frontiers in Pharmacology. 12. 634822–634822. 22 indexed citations
8.
9.
10.
Wei, Jia, Min Xiao, Zekai Mao, et al.. (2020). Anti CD19/22 Cocktail CAR T-Cell Therapy Can Improve the Outcomes of Patients with TP53-Mutated Relapsed/Refractory B-Cell Lymphoma. Blood. 136(Supplement 1). 43–43. 1 indexed citations
11.
Huang, Xiaojian, Bowei Ni, Zekai Mao, et al.. (2019). NOV/CCN3 induces cartilage protection by inhibiting PI3K/AKT/mTOR pathway. Journal of Cellular and Molecular Medicine. 23(11). 7525–7534. 40 indexed citations
12.
Huang, Xiaojian, Xi Yang, Zekai Mao, et al.. (2019). Vanillic acid attenuates cartilage degeneration by regulating the MAPK and PI3K/AKT/NF-κB pathways. European Journal of Pharmacology. 859. 172481–172481. 58 indexed citations
13.
Huang, Xiaojian, et al.. (2018). Caffeic acid protects against IL-1β-induced inflammatory responses and cartilage degradation in articular chondrocytes. Biomedicine & Pharmacotherapy. 107. 433–439. 41 indexed citations
14.
Mao, Zekai, et al.. (2018). Pravastatin alleviates interleukin 1β-induced cartilage degradation by restoring impaired autophagy associated with MAPK pathway inhibition. International Immunopharmacology. 64. 308–318. 22 indexed citations
15.
Wang, Pengcheng, Zekai Mao, Rui Lu, et al.. (2018). Histone deacetylase-4 and histone deacetylase-8 regulate interleukin-1β-induced cartilage catabolic degradation through MAPK/JNK and ERK pathways. International Journal of Molecular Medicine. 41(4). 2117–2127. 40 indexed citations
16.
Huang, Xiaojian, Zekai Mao, Pengcheng Wang, et al.. (2018). Kaempferol inhibits interleukin‑1β stimulated matrix metalloproteinases by suppressing the MAPK‑associated ERK and P38 signaling pathways. Molecular Medicine Reports. 18(3). 2697–2704. 37 indexed citations
17.
Huang, Xiaojian, et al.. (2017). Sinapic Acid Inhibits the IL-1β-Induced Inflammation via MAPK Downregulation in Rat Chondrocytes. Inflammation. 41(2). 562–568. 33 indexed citations
18.
Li, Wenkai, et al.. (2015). Chondrogenic effect of cell-based scaffold of self-assembling peptides/PLGA-PLL loading the hTGFβ3 plasmid DNA. Journal of Materials Science Materials in Medicine. 27(1). 19–19. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna‐Lena Mueller Breakdown of academic impact, for papers by Myung-Soon Sung Breakdown of academic impact, for papers by Sung Chul Kwak Breakdown of academic impact, for papers by Niloufar Mohammadkhani Breakdown of academic impact, for papers by Mozhen Liu Breakdown of academic impact, for papers by Supriya Jagga Breakdown of academic impact, for papers by Yonghui Dong Breakdown of academic impact, for papers by Bowei Ni Breakdown of academic impact, for papers by Nianhu Li Breakdown of academic impact, for papers by Yin Zhao
Rankless by CCL
2026